- Home
- ORIC vs APOG Comparison
ORIC vs APOG Comparison
Compare ORIC & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- APOG
- Stock Information
- Founded
- ORIC 2014
- APOG 1949
- Country
- ORIC United States
- APOG United States
- Employees
- ORIC N/A
- APOG N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- APOG Auto Parts:O.E.M.
- Sector
- ORIC Health Care
- APOG Consumer Discretionary
- Exchange
- ORIC Nasdaq
- APOG Nasdaq
- Market Cap
- ORIC 974.1M
- APOG 919.3M
- IPO Year
- ORIC 2020
- APOG N/A
- Fundamental
- Price
- ORIC $10.88
- APOG $43.62
- Analyst Decision
- ORIC Strong Buy
- APOG Hold
- Analyst Count
- ORIC 10
- APOG 1
- Target Price
- ORIC $17.33
- APOG $45.00
- AVG Volume (30 Days)
- ORIC 782.2K
- APOG 116.8K
- Earning Date
- ORIC 08-12-2025
- APOG 10-03-2025
- Dividend Yield
- ORIC N/A
- APOG 2.37%
- EPS Growth
- ORIC N/A
- APOG N/A
- EPS
- ORIC N/A
- APOG 2.36
- Revenue
- ORIC N/A
- APOG $1,376,100,000.00
- Revenue This Year
- ORIC N/A
- APOG $6.91
- Revenue Next Year
- ORIC N/A
- APOG $0.41
- P/E Ratio
- ORIC N/A
- APOG $18.54
- Revenue Growth
- ORIC N/A
- APOG N/A
- 52 Week Low
- ORIC $3.90
- APOG $37.53
- 52 Week High
- ORIC $14.67
- APOG $87.93
- Technical
- Relative Strength Index (RSI)
- ORIC 63.04
- APOG 52.81
- Support Level
- ORIC $9.87
- APOG $41.79
- Resistance Level
- ORIC $10.35
- APOG $44.94
- Average True Range (ATR)
- ORIC 0.44
- APOG 1.13
- MACD
- ORIC 0.14
- APOG -0.10
- Stochastic Oscillator
- ORIC 79.99
- APOG 52.81
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About APOG Apogee Enterprises Inc.
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.